@article{JTD22421,
author = {Solenn Brosseau and Valérie Gounant and Gérard Zalcman},
title = {(J)ALEX the great: a new era in the world of ALK inhibitors},
journal = {Journal of Thoracic Disease},
volume = {10},
number = {Suppl 18},
year = {2018},
keywords = {},
abstract = {Anaplastic lymphoma kinase (ALK) gene rearrangement defines a recently identified molecular subtype of non-small cell lung cancer (NSCLC), which accounts for 4–5% of all non-squamous NSCLC (1).},
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/22421}
}